Tirzepatide Weight Loss - Step 3

Tirzepatide is a medication that belongs to a class of drugs known as GLP-1 receptor agonists and is a GIP. By targeting both receptors, Tirzepatide enhances insulin secretion and reduces glucagon secretion in a glucose-dependent manner, contributing to improved glycemic control. In addition to its glucose-lowering effects, Tirzepatide has been associated with significant weight loss in clinical trials.

What’s Included:

• Medical Consult: Discuss your treatment plan with one of our licensed MDs
• Medications/Supplements: Medication, directions and supplies are included for a 1 month supply for self-administration of 6.375mg of Tirzepatide-Glycine (8.5mg-5mg per ml) for four weeks.

---

Includes

Telehealth Visit (optional), Tirzepatide